TScan Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2022 to Q2 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
TScan Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2022 to Q2 2025.
  • TScan Therapeutics, Inc. Current Ratio for the quarter ending June 30, 2025 was 829 %, a 25.9% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2025 829 +171 +25.9% Jun 30, 2025
Q1 2025 843 +211 +33.4% Mar 31, 2025
Q4 2024 766 +92.4 +13.7% Dec 31, 2024
Q3 2024 726 +38.1 +5.55% Sep 30, 2024
Q2 2024 659 -73.9 -10.1% Jun 30, 2024
Q1 2024 632 -129 -17% Mar 31, 2024
Q4 2023 673 -104 -13.4% Dec 31, 2023
Q3 2023 687 -104 -13.1% Sep 30, 2023
Q2 2023 732 -53 -6.75% Jun 30, 2023
Q1 2023 761 +31.2 +4.28% Mar 31, 2023
Q4 2022 777 Dec 31, 2022
Q3 2022 791 Sep 30, 2022
Q2 2022 785 Jun 30, 2022
Q1 2022 730 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.